Oren Gilad
-
Doylestown’s Aprea Therapeutics Names Industry Veteran as Chief Medical Advisor
Doylestown-based Aprea Therapeutics has named Eugene Kennedy, MD, as chief medical advisor, adding a seasoned leader in oncology drug development to its executive team. Aprea…
-
Doylestown Cancer Pharma Moves Closer to Starting Clinical Testing on Its 3rd Experimental Cancer Treatment
Doylestown-based Aprea Therapeutics is moving closer to entering clinical testing with its third potential experimental cancer treatment, writes John George for the Philadelphia Business Journal.…
-
Doylestown Biopharmaceutical Company Reports Second Quarter Finanical Results
Aprea Therapeutics, Inc., headquarted at 3805 Old Easton Road in Doylestown, has reported their financial results for the second fiscal quarter of 2023. Staff writers…
Founding Partners
Advertisement
Affiliate Partners
